Norisoboldine Alleviates Isoproterenol‐Induced Myocardial Ischemic Injury via the TLR4 – MyD88 ‐Dependent NF ‐ κB Activation Pathway and Modulation of L‐Type Calcium Channels
Clinical and Experimental Pharmacology and Physiology · 2025
DOI: 10.1111/1440-1681.70033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Pharmacology and Physiology, 2025. Verfasst von Xin Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Integrative Chinese and Western Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China. Hauptthemen laut MEDLINE: Toll-Like Receptor 4, Isoproterenol, Myeloid Differentiation Factor 88, NF-kappa B. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Ministry of Education's 'Chunhui Plan' Cooperative Research Project, Fund Project of Central Guided Local Science and Technology Development of Hebei Province, Key Project of the Joint Fund of Traditional Chinese Medicine of the Natural Science Foundation of Hebei Province.
Abstract (Originalsprache)
Norisoboldine (NIB) displays beneficial effects on cardiovascular diseases, although its protective role and underlying mechanisms in myocardial ischemia (MI) injury remain elusive. The aim of this study is to explore the potential cardioprotective mechanism of NIB on MI injury caused by isoproterenol (ISO). We administered NIB to SD rats at 20 and 40 mg/kg daily for 7 days in this study; this was followed by an ISO injection to induce MI injury. Parameters such as electrocardiogram readings, heart rate, serum concentrations of creatine kinase (CK) and creatine kinase‐MB (CK‐MB), levels of inflammatory markers, some histopathological assessments and oxidative stress markers were evaluated. We conducted Western blot analyses to evaluate protein expression related to apoptosis and the TLR4–MyD88‐mediated NF‐κB activation pathway. The L‐type Ca 2+ current (ICa‐L) and contraction of isolated ventricular cells from rats were identified using patch‐clamp methods and the IonOptix detection system. The treatment with NIB resulted in improvements in heart rate and ST‐segment changes, a reduction in CK and CK‐MB levels, the restoration of superoxide dismutase, catalase and glutathione levels and a decrease in malondialdehyde accumulation. Furthermore, NIB reduced the expression of inflammatory markers, lowered Ca 2+ levels and reactive oxygen species production and improved myocardial tissue morphology. It also countered ISO‐induced alterations in apoptosis and the TLR4–MyD88‐dependent NF‐κB activation pathway. Additionally, NIB considerably attenuated ICa‐L and reduced the contractile function of cardiomyocytes. These results suggest that NIB effectively mitigates ISO‐induced MI injury through anti‐inflammatory, antioxidative, and anti‐apoptotic mechanisms, potentially involving the TLR4–MyD88‐dependent NF‐κB activation pathway and calcium balance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Integrative Chinese and Western Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China.
- College of Basic Medicine Sciences, Hebei University of Chinese Medicine, Shijiazhuang, China.
- Xingtai Medical College, Xingtai, China.
- College of Pharmacology, Hebei University of Chinese Medicine, Shijiazhuang, China.
- Hebei International Cooperation Center for Ion Channel Function and Innovative Traditional Chinese Medicine, Shijiazhuang, China.
ORCID-Profile: Yonggang Gao
Förderung
- Ministry of Education's 'Chunhui Plan' Cooperative Research Project
- Fund Project of Central Guided Local Science and Technology Development of Hebei Province
- Key Project of the Joint Fund of Traditional Chinese Medicine of the Natural Science Foundation of Hebei Province
- Natural Science Fund Project of Hebei Province
- Special Project of Basic Scientific Research Operating Fee for Provincial Colleges and Universities from Hebei University of Chinese Medicine
Zitieren
APA
Zhang, X., Wang, X., Wang, Y., Ma, X., Geng, Y., Zang, S., Ban, Z., Jia, Y., & Gao, Y. (2025). Norisoboldine Alleviates Isoproterenol‐Induced Myocardial Ischemic Injury via the TLR4 – MyD88 ‐Dependent NF ‐ κB Activation Pathway and Modulation of L‐Type Calcium Channels. Clinical and Experimental Pharmacology and Physiology. https://doi.org/10.1111/1440-1681.70033
Vancouver
Zhang X, Wang X, Wang Y, Ma X, Geng Y, Zang S, et al. Norisoboldine Alleviates Isoproterenol‐Induced Myocardial Ischemic Injury via the TLR4 – MyD88 ‐Dependent NF ‐ κB Activation Pathway and Modulation of L‐Type Calcium Channels. Clinical and Experimental Pharmacology and Physiology. 2025. doi:10.1111/1440-1681.70033
BibTeX
@article{Zhang2025,
author = {Zhang, Xin and Wang, Xinliu and Wang, Yuanyuan and Ma, Xingyou and Geng, Yunyun and Zang, Shuxian and Ban, Ziyun and Jia, Yugai and Gao, Yonggang},
title = {Norisoboldine Alleviates Isoproterenol‐Induced Myocardial Ischemic Injury via the TLR4 – MyD88 ‐Dependent NF ‐ κB Activation Pathway and Modulation of L‐Type Calcium Channels},
journal = {Clinical and Experimental Pharmacology and Physiology},
year = {2025},
doi = {10.1111/1440-1681.70033}
}
EUVIMED